In recent weeks, there have been several important studies and guidelines published that have served to improve our understanding of treating critically ill patients with COVID-19 infection. In this podcast, we highlight the latest update from the SSC and discuss studies on convalescent plasma and IL-6 antagonists.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine. ...
Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties. In recent years, several...
He's back! Bryan Hayes joins the podcast to discuss the latest evidence pertaining to the reversal of life-threatening hemorrhage secondary to the direct oral...